Vigil Neuroscience | ARS: Annual Report to Security Holders
Vigil Neuroscience | DEFA14A: Others
Vigil Neuroscience | DEF 14A: Definitive information statements
Vigil Neuroscience | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Vigil Neuroscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(4.9%),Invus Public Equities Advisors, LLC(4.9%), etc.
Vigil Neuroscience | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Vigil Neuroscience | 10-K: Annual report
Vigil Neuroscience | 8-K: Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Vigil Neuroscience | 3: Initial statement of beneficial ownership of securities-Officer Kaufmann Petra
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Kaufmann Petra
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Director Booth Bruce
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Director Bruhn Suzanne Louise
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Director Blanchard Cheryl R
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Verni Christopher
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Ziolkowski Jennifer Lynn
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Magovcevic-Liebisch Ivana
Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Gray David L. F.
Vigil Neuroscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(6.0%),Citadel Advisors Holdings LP(6.0%), etc.
Vigil Neuroscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(9.62%),Deep Track Biotechnology Master Fund, Ltd.(9.62%), etc.
Vigil Neuroscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt, L.P.(3.27%),Deerfield Management Company, L.P.(3.27%), etc.
No Data